Consultants for Clin. Rsrch
Cincinnati, Ohio 45219
0 studies enrolling now · 2 studies all time
What they study most
Ulcerative Colitis
Studies at this site
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
— Stopped early
Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis
— Completed